论文部分内容阅读
目的分析全胸腔镜下肺楔形切除术治疗早期肺癌的疗效。方法对收治的早期肺癌行全胸腔镜微创手术患者40例采用随机数表法将其分为观察组与对照组,每组20例,对照组患者行全胸腔镜下肺叶切除术治疗,观察组行全胸腔镜下肺楔形切除术,比较两组患者手术疗效、生存时间及术后并发症等指标。结果观察组患者手术时间、术中出血量、术后胸腔引流管留置时间、总引流量明显低于对照组,差异有统计学意义(P<0.05);观察组患者视觉模拟评分法(VAS)明显低于对照组,观察组无疾病进展生存期为11.3个月(95%CI:6.9~10.6),中位生存期为30.9个月(95%CI:20.5~25.2);对照组无疾病进展生存期及中位生存期略高于观察组,但两组比较,差异无统计学意义(P>0.05);两组患者并发症发生率比较差异无统计学意义(P>0.05)。结论全胸腔镜下肺楔形切除术具有医源性创伤低、疼痛轻、术后恢复迅速的特点,可有效清除肺部病灶,患者生存期与肺叶切除术基本无差异,可作为不耐受肺叶切除术或合并其他高危疾病的肺癌患者患者治疗手段。
Objective To analyze the effect of total thoracoscopic wedge resection for early lung cancer. Methods Forty patients with minimally invasive thoracoscopic surgery for early lung cancer admitted to our hospital were divided into the observation group and the control group by random number table. Each group had 20 cases. The patients in the control group underwent thoracoscopic lobectomy. Group thoracoscopic wedge resection of the lungs, the two groups were compared the efficacy of surgery, survival time and postoperative complications and other indicators. Results The operation time, intraoperative blood loss, postoperative thoracic drainage tube indwelling time and total drainage volume in the observation group were significantly lower than those in the control group (P <0.05). Visual analog scale (VAS) (95% CI: 6.9-10.6). The median survival time was 30.9 months (95% CI: 20.5-25.2). The control group had no disease progression Survival and median survival was slightly higher than the observation group, but there was no significant difference between the two groups (P> 0.05). There was no significant difference in complication rates between the two groups (P> 0.05). Conclusions Thoracoscopic pulmonary wedge resection is characterized by low iatrogenic trauma, light pain and rapid postoperative recovery. It is effective in removing lung lesions. The survival time of patients is almost the same as that of lobectomy. Resection or other high-risk patients with lung cancer patients with treatment.